Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on IPC The Hospitalist Company

Related IPCM
IPC Healthcare Acquires Mid-Atlantic ElderCare, Broadens Presence in Three States, no terms
Benzinga's Top Downgrades

In a report published Friday, Jefferies & Company reiterated its Hold rating on IPC The Hospitalist Company (NASDAQ: IPCM), but lowered its price target from $47.00 to $40.00.

Jefferies noted, “IPC's Q3 miss -- driven by contract exits and volume weakness in the company's host hospitals -- and associated guidance cut puts the stock back in the penalty box as investors re-evaluate the company's fundamental outlook. While IPC's performance (12% revenue and 19% EPS growth) is nothing to sneeze at, we also recognize that its risk profile has changed and will likely result in a NT valuation reset.”

IPC The Hospitalist Company closed on Thursday at $41.90.

Latest Ratings for IPCM

Aug 2015JefferiesDowngradesBuyHold
Aug 2015William BlairDowngradesOutperformMarket Perform
Aug 2015DoughertyDowngradesNeutralSell

View More Analyst Ratings for IPCM
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (IPCM)

View Comments and Join the Discussion!